Skip to main content
. 2019 Nov 17;9(1):215–224. doi: 10.1002/cam4.2704

Figure 2.

Figure 2

Kaplan‐Meier estimates of overall survival (OS) by baseline composite Edmonton Symptom Assessment Scale (ESAS) scores. OS in 2043 advanced pancreatic cancer patients who reported baseline composite ESAS scores prior to receiving first‐line chemotherapy treatment. A, Baseline composite total symptom distress scores (TSDS), (B) Baseline composite physical symptom scores (PHS), and (C) Baseline composite psychological symptom scores (PSS)